TNF and inflammatory bowel disease: In a meta‐regression of 8 cross‐sectional studies9 and a pilot longitudinal study of 32 patients with IBD,14 we hypothesized that the increased arterial stiffness detected in patients with IBD could be at least partly reversed by anti–tumor necrosis factor‐alpha (anti‐TNFα) therapy, as already reported in another model of chronic inflammation.15